Lorem Ipsum is simply dummy text of the printing and typesetting industry.Lorem
Ipsum has been the industry standard dummy text ever since the when an unknown
printer took a galley of type and scrambled.

Meeting on the Mesa

Save the dates for this year’s hybrid conference October 12-14, 2021! We can’t wait to see you all again in-person in Carlsbad, CA for the sector’s premier event.

Electroporation Systems

ATx

From small to medium static Electroporation.

STx

Transfect up to 20 billion cells with scalable static or flow-through electroporation.

GTx

Transfect up to 20 billion cells with our clinically validated and cGMP compliant flow-through electroporation.

VLx

For gram scale protein production.

Applications

Gene Editing

Navigate the complexities of genome engineering with highly efficient delivery.

Protein & Antibody Production

Accelerate biotherapeutic development with transient expression for gram-scale protein production.

Cell Therapy

Discover scalable engineering to enable safe and potent cell therapies.

Viral Vector

Transfect adherent or suspension cells to produce a variety of viral vectors.

Cell Based Assays

Produce assay-ready cells faster with scalable electroporation.

Vaccine Development

Innovate vaccine research with our adaptable platform for production of recombinant proteins, virus-like particles.

Industries

Cell & Gene Therapy

Partnering with developers to accelerate development and scale cell therapy programs toward clinical success.

Discovery & Translational Research

Accelerating breakthrough discoveries with high-efficiency, reproducible electroporation across cell types.

Bioprocessing

Enabling efficient, reproducible transfection in virtually any cell type for high-yield transient expression and rapid cell line development.